Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Fluorescence lifetime imaging of cellular heterogeneity in cancer drug response

Open Access Open Access

Abstract

Cancer is a heterogeneous disease, and sub-populations of cells can drive drug resistance. Fluorescence lifetime imaging of metabolic co-factors is used to monitor drug response on a cellular level, to optimize treatment strategies for patients.

© 2015 Optical Society of America

PDF Article
More Like This
Fluorescence lifetime imaging of cellular-level metabolic heterogeneity in cancer

Melissa C. Skala
CL_2_3 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2015

Imaging Cellular Metabolic Heterogeneity in Cancer

Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, and Ingrid Meszoely
JW4A.1 Cancer Imaging and Therapy (Cancer) 2016

Fluorescence Lifetime Imaging of Treatment Response in Neuroendocrine Tumor Organoids

Amani Gillette, Cheri Pasch, Chris Babiarz, Dustin Deming, and Melissa Skala
OmS2D.6 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved